Q
Qifu Li
Researcher at Chongqing Medical University
Publications - 136
Citations - 3031
Qifu Li is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 108 publications receiving 1905 citations. Previous affiliations of Qifu Li include University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Standards of medical care for type 2 diabetes in China 2019.
Weiping Jia,Jianping Weng,Dalong Zhu,Linong Ji,Juming Lu,Zhiguang Zhou,Dajin Zou,Lixin Guo,Qiuhe Ji,Li Chen,Liming Chen,Jingtao Dou,Xiaohui Guo,Hongyu Kuang,Ling Li,Qifu Li,Xiaoying Li,Jing Liu,Xingwu Ran,Lixin Shi,Guangyao Song,Xinhua Xiao,Liyong Yang,Zhigang Zhao +23 more
TL;DR: The main contents include epidemiology of type 2 diabetes in China; diagnosis and classification of diabetes; primary, secondary, and tertiary diabetes prevention; diabetes education and management support; blood glucose monitoring; integrated control targets for type 1 diabetes and treatments for hyperglycaemia.
Journal ArticleDOI
Standards of care for type 2 diabetes in China
Jianping Weng,Linong Ji,Weiping Jia,Juming Lu,Zhiguang Zhou,Dajin Zou,Dalong Zhu,Liming Chen,Li Chen,Lixin Guo,Xiaohui Guo,Qiuhe Ji,Qifu Li,Xiaoying Li,Jing Liu,Xingwu Ran,Zhongyan Shan,Lixin Shi,Guangyao Song,Liyong Yang,Yu-zhi Yang,Wenying Yang +21 more
TL;DR: Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Department of Endocrineology, Peking University People’s Hospital, Beijing, China Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key laboratory of Diabetes Mellitus.
Journal ArticleDOI
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Xianjun Luo,Honggui Li,Linqiang Ma,Jing Zhou,Xin Guo,Shih Lung Woo,Ya Pei,Linda R. Knight,Michael A. Deveau,Yanming Chen,Xiaoxian Qian,Xiaoqiu Xiao,Qifu Li,Xiangbai Chen,Yuqing Huo,Kelly McDaniel,Heather Francis,Heather Francis,Shannon Glaser,Shannon Glaser,Fanyin Meng,Gianfranco Alpini,Gianfranco Alpini,Chaodong Wu +23 more
TL;DR: Levels of STing were increased in liver tissues from patients with NAFLD and mice with HFD-induced steatosis and in mice, loss of STING from macrophages decreased the severity of liver fibrosis and the inflammatory response.
Journal ArticleDOI
Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Shih Lung Woo,Hang Xu,Honggui Li,Yan Zhao,Xiang Hu,Xiang Hu,Jiajia Zhao,Jiajia Zhao,Xin Guo,Ting Guo,Rachel Botchlett,Ting Qi,Ya Pei,Juan Zheng,Juan Zheng,Yiming Xu,Xiaofei An,Lulu Chen,Lili Chen,Qifu Li,Xiaoqiu Xiao,Yuqing Huo,Yuqing Huo,Chaodong Wu +23 more
TL;DR: It is suggested that metformin protects against obesity-associated NAFLD largely through direct effects on decreasing hepatocyte fat deposition and on inhibiting inflammatory responses in both hepatocytes and macrophages.
Journal ArticleDOI
AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity.
Ting Luo,Allison Nocon,Jessica L. Fry,Alex Sherban,Xianliang Rui,Bingbing Jiang,X. Julia Xu,Jingyan Han,Yun Yan,Qin Yang,Qifu Li,Mengwei Zang +11 more
TL;DR: Treatment with the antidiabetic drug metformin inhibits excessive ECM deposition in WAT of ob/ob mice and mice with diet-induced obesity, as evidenced by decreased collagen deposition surrounding adipocytes and expression of fibrotic genes including the collagen cross-linking regulator LOX.